Denne siden ble automatisk oversatt og nøyaktigheten av oversettelsen er ikke garantert. Vennligst referer til engelsk versjon for en kildetekst.

The Short-term Effects of Noninvasive Electrical Brain Stimulation on Dual Tasking in Older Adults

14. mars 2022 oppdatert av: Brad Manor, Hebrew SeniorLife

Optimization of Transcranial Direct Current Stimulation (tDCS) for Dual Task Performance in Older Adults With and Without a History of Falls

The tDCS & Dual Tasking study will compare the effects of transcranial Direct Current Stimulation (tDCS) targeting three different cortical regions (as well as sham stimulation) on dual task standing and walking in older adults with and without a recent history of recurrent falls.

Studieoversikt

Status

Fullført

Forhold

Intervensjon / Behandling

Detaljert beskrivelse

The ability to stand and walk safely, especially while performing additional cognitive tasks like talking, reading or decision making, is critical to the preservation of functional independence into old age. Such "dual tasking" often impairs balance, even in healthy older adults and those with greater dual task "costs" are more likely to suffer future falls. Transcranial direct current stimulation (tDCS) is a safe, noninvasive and inexpensive means of modulating activity across cortical networks. A single, 20-minute session of tDCS facilitates brain activity for up to 24 hours. Through Dr. Manor's previous research in healthy older adults, he has discovered that just 20 minutes of tDCS targeting the left dorsolateral prefrontal cortex (dlPFC)-a region involved in both cognitive and motor function-immediately reduces the dual task costs to balance when standing and walking, and improves performance in the timed up-and-go (TUG) test of mobility. However, there are several brain networks with known involvement in balance control and dual tasking, and the optimal brain region to target to improve dual task capacity has not been established. The proposed study will be a double-blinded, sham-controlled study in which older adults both with and without a history of falling undergo dual task assessments immediately before and after single, 20-minute sessions of tDCS designed to target several different brain regions with known involvement in dual tasking and the maintenance of balance.

Studietype

Intervensjonell

Registrering (Faktiske)

61

Fase

  • Ikke aktuelt

Kontakter og plasseringer

Denne delen inneholder kontaktinformasjon for de som utfører studien, og informasjon om hvor denne studien blir utført.

Studiesteder

  • Forente stater
    • Massachusetts
      • Roslindale, Massachusetts, Forente stater, 02131
        • Hebrew Rehabilitation Center
  • Israel
      • Tel Aviv, Israel, 64239
        • Laboratory for Gait and Neurodynamics, Tel Aviv Sourasky Medical Center

Deltakelseskriterier

Forskere ser etter personer som passer til en bestemt beskrivelse, kalt kvalifikasjonskriterier. Noen eksempler på disse kriteriene er en persons generelle helsetilstand eller tidligere behandlinger.

Kvalifikasjonskriterier

Alder som er kvalifisert for studier

65 år og eldre (Eldre voksen)

Tar imot friske frivillige

Ja

Kjønn som er kvalifisert for studier

Alle

Beskrivelse

Inclusion Criteria:

"Faller" group

  • Aged 65 years and older
  • Able to read, write and communicate in English
  • Self-report of 2 or more falls within the past 6 months

"Non-Faller" Group

  • Aged 65 years and older
  • Able to read, write, and communicate in English
  • Self-report of 1 or no (zero) falls within the past 6 months

Exclusion Criteria:

  • Self-reported diagnosis of Parkinson's disease, Alzheimer's disease or dementia, multiple sclerosis, history of stroke or other neurodegenerative disorder.
  • Self-reported active cancer for which chemo-/radiation therapy is being received.
  • Hospitalization within the past 3 months due to acute illness or as a result of a musculoskeletal injury significantly affecting gait and balance.
  • Montreal Cognitive Assessment score <18, or insufficient understanding of study procedures following review of the Informed Consent Form. Understanding will be assessed by asking the participant to answer the following three questions: 1) What is the purpose of this study? 2) What are the risks of study involvement? 3) If you decide to participate, are you allowed to withdraw from the study at any time? Answers will be recorded by study personnel on the "Assessment of Protocol Understanding" form (see attached). Insufficient understanding will be defined by one or more incorrect answers, as determined at the discretion of the investigator.
  • Inability to stand or ambulate unassisted for at least 25 feet.
  • Contraindications to tDCS, including a reported seizure within the past two years, use of neuro-active drugs, the risk of metal objects in the brain, skull, or head, self-reported presence of specific implanted medical devices (e.g., deep brain stimulator, medication infusion pump, cochlear implant), or the presence of any active dermatological condition, such as eczema, on the scalp (see appendix for standardized tDCS screening questionnaire).

Studieplan

Denne delen gir detaljer om studieplanen, inkludert hvordan studien er utformet og hva studien måler.

Hvordan er studiet utformet?

Designdetaljer

  • Primært formål: Grunnvitenskap
  • Tildeling: Randomisert
  • Intervensjonsmodell: Crossover-oppdrag
  • Masking: Firemannsrom

Våpen og intervensjoner

Deltakergruppe / Arm
Intervensjon / Behandling
Sham-komparator: Sham Stimulation
The Sham stimulation intervention will consist of one, twenty-minute session of transcranial direct current stimulation (tDCS) that does not target a cortical area but instead, provides just enough current to create tingling sensations across the scalp to mimic the feeling of receiving the real stimulation. The sham stimulation will use the same number and placement of electrodes as the real stimulation but with a much smaller total current intensity of 0.5 milliamps (mA).
Annen: transcranial Direct Current Stimulation (tDCS)
There will be three different tDCS targets as well as a sham stimulation condition. The stimulation for each of these conditions will be delivered via 6 already-placed gel electrodes on the participant's scalp with different combinations of current intensities among all the electrodes.
Eksperimentell: M1 Stimulation
The M1 stimulation intervention consists of one, twenty-minute session of transcranial direct current stimulation (tDCS) targeting the primary motor cortex at a total current intensity of 1.5 mA.
Annen: transcranial Direct Current Stimulation (tDCS)
There will be three different tDCS targets as well as a sham stimulation condition. The stimulation for each of these conditions will be delivered via 6 already-placed gel electrodes on the participant's scalp with different combinations of current intensities among all the electrodes.
Eksperimentell: DLPFC Stimulation
The DLPFC stimulation intervention consists of one, twenty-minute session of transcranial direct current stimulation (tDCS) targeting the dorsolateral prefrontal cortex at a total current intensity of 1.5 mA.
Annen: transcranial Direct Current Stimulation (tDCS)
There will be three different tDCS targets as well as a sham stimulation condition. The stimulation for each of these conditions will be delivered via 6 already-placed gel electrodes on the participant's scalp with different combinations of current intensities among all the electrodes.
Eksperimentell: M1+DLPFC Stimulation
The M1+DLPFC stimulation intervention consists of one, twenty-minute session of transcranial direct current stimulation (tDCS) targeting the primary motor cortex and the dorsolateral prefrontal cortex simultaneously at a total current intensity of 3.0 mA.
Annen: transcranial Direct Current Stimulation (tDCS)
There will be three different tDCS targets as well as a sham stimulation condition. The stimulation for each of these conditions will be delivered via 6 already-placed gel electrodes on the participant's scalp with different combinations of current intensities among all the electrodes.

Hva måler studien?

Primære resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
Dual task cost to standing postural sway speed
Tidsramme: This outcome will be assessed immediately before and after each 20-minute session of tDCS.
The dual task cost to standing postural sway speed will be calculated from trials of standing with and without simultaneous performance of a serial subtraction cognitive task. The dual task cost will be calculated as the percent change in sway speed from single- to dual-task conditions.
This outcome will be assessed immediately before and after each 20-minute session of tDCS.
Dual task cost to gait speed when walking
Tidsramme: This outcome will be assessed immediately before and after each 20-minute session of tDCS.
The dual task cost to gait speed when walking will be calculated from trials of walking with and without simultaneous performance of a serial subtraction cognitive task. The dual task cost will be calculated as the percent change in gait speed from single- to dual-task conditions.
This outcome will be assessed immediately before and after each 20-minute session of tDCS.

Sekundære resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
Dual task cost to postural sway area
Tidsramme: This outcome will be assessed immediately before and after each 20-minute session of tDCS.
The dual task cost to standing postural sway area will be calculated from trials of standing with and without simultaneous performance of a serial subtraction cognitive task. The dual task cost will be calculated as the percent change in postural sway area from single- to dual-task conditions.
This outcome will be assessed immediately before and after each 20-minute session of tDCS.
Dual task cost to gait variability when walking
Tidsramme: This outcome will be assessed immediately before and after each 20-minute session of tDCS.
The dual task cost to gait variability when walking will be calculated from trials of walking with and without simultaneous performance of a serial subtraction cognitive task. Gait variability will be defined as the coefficient of variation about the average stride time (stride times defined by the time between consecutive heel strides of the same leg). The dual task cost will be calculated as the percent change in gait variability from single- to dual-task conditions.
This outcome will be assessed immediately before and after each 20-minute session of tDCS.
Single task postural sway speed
Tidsramme: This outcome will be assessed immediately before and after each 20-minute session of tDCS.
Single task postural sway speed will be calculated from trials of standing without simultaneous performance of a serial subtraction cognitive task.
This outcome will be assessed immediately before and after each 20-minute session of tDCS.
Single task postural sway area
Tidsramme: This outcome will be assessed immediately before and after each 20-minute session of tDCS.
Single task postural sway area will be calculated from trials of standing without simultaneous performance of a serial subtraction cognitive task.
This outcome will be assessed immediately before and after each 20-minute session of tDCS.
Single task gait speed variability when walking
Tidsramme: This outcome will be assessed immediately before and after each 20-minute session of tDCS.
Single task gait variability when walking will be calculated from trials of walking without simultaneous performance of a serial subtraction cognitive task. Gait variability will be defined as the coefficient of variation about the average stride time (stride times defined by the time between consecutive heel strides of the same leg).
This outcome will be assessed immediately before and after each 20-minute session of tDCS.
Single task gait speed when walking
Tidsramme: This outcome will be assessed immediately before and after each 20-minute session of tDCS.
Single task gait speed when walking will be calculated from trials of walking without simultaneous performance of a serial subtraction cognitive task.
This outcome will be assessed immediately before and after each 20-minute session of tDCS.
Mobility
Tidsramme: This outcome will be assessed immediately before and after each 20-minute session of tDCS.
Mobility will be assessed using the Timed Up-and-Go test in which the amount of time it takes for the participant to stand up from a chair, walk three meters, turn around a cone, walk back, and sit down is recorded.
This outcome will be assessed immediately before and after each 20-minute session of tDCS.
Executive function
Tidsramme: This outcome will be assessed immediately before and after each 20-minute session of tDCS.
Executive function will be assessed using the Stroop test.
This outcome will be assessed immediately before and after each 20-minute session of tDCS.
Cognitive processing speed
Tidsramme: This outcome will be assessed immediately before and after each 20-minute session of tDCS.
Cognitive processing speed will be assessed using the Symbol Digit Modalities Test (SDMT).
This outcome will be assessed immediately before and after each 20-minute session of tDCS.
Attention
Tidsramme: This outcome will be assessed immediately before and after each 20-minute session of tDCS
Attention will be assessed using the Visual Search and Attention Test (VSAT).
This outcome will be assessed immediately before and after each 20-minute session of tDCS

Samarbeidspartnere og etterforskere

Det er her du vil finne personer og organisasjoner som er involvert i denne studien.

Sponsor

Hebrew SeniorLife

Etterforskere

  • Hovedetterforsker: Brad Manor, Institute for Aging Research, Hebrew SeniorLife

Studierekorddatoer

Disse datoene sporer fremdriften for innsending av studieposter og sammendragsresultater til ClinicalTrials.gov. Studieposter og rapporterte resultater gjennomgås av National Library of Medicine (NLM) for å sikre at de oppfyller spesifikke kvalitetskontrollstandarder før de legges ut på det offentlige nettstedet.

Studer hoveddatoer

Studiestart (Faktiske)

26. mai 2017

Primær fullføring (Faktiske)

26. november 2019

Studiet fullført (Faktiske)

26. mai 2021

Datoer for studieregistrering

Først innsendt

15. juni 2017

Først innsendt som oppfylte QC-kriteriene

15. juni 2017

Først lagt ut (Faktiske)

19. juni 2017

Oppdateringer av studieposter

Sist oppdatering lagt ut (Faktiske)

15. mars 2022

Siste oppdatering sendt inn som oppfylte QC-kriteriene

14. mars 2022

Sist bekreftet

1. mars 2022

Mer informasjon

Begreper knyttet til denne studien

Nøkkelord

Andre studie-ID-numre

  • 2016-26

Plan for individuelle deltakerdata (IPD)

Planlegger du å dele individuelle deltakerdata (IPD)?

NEI

Legemiddel- og utstyrsinformasjon, studiedokumenter

Studerer et amerikansk FDA-regulert medikamentprodukt

Nei

Studerer et amerikansk FDA-regulert enhetsprodukt

Nei

Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .

Kliniske studier på transcranial Direct Current Stimulation (tDCS)

Søk i lignende forsøk

Sponsorer og samarbeidspartnere

Medisinsk tilstand

Legemiddelintervensjoner

CROs by country

CROs in Denmark

Forhold

Sjeldne sykdommer

Legemiddelintervensjoner

Kosttilskudd

Sponsor / samarbeidspartnere

Steder

Abonnere